Avidity pledges support to Oceana

Avidity Avitag™ Technology


Avidity develops and sells molecular affinity tools for connecting molecules. Our patented AviTag™ technology employs a highly targeted enzymatic conjugation of a single biotin on a unique 15 amino acid peptide tag using the biotin ligase (BirA) from E. coli. AviTag™ sequence is GLNDIFEAQKIEWHE. Oriented on streptavidin-coated surfaces, this creates an ideal presentation for molecular binding interactions.

The scientific benefits of Avidity's AviTag Technology have garnered notice. Currently, AviTag technology is licensed by seven of the world's top ten pharmaceutical companies and is used by researchers in 22 countries.

Join Avidity's Collaborative Online (Scientific) Community >>
We are moving into greater investigation of bioluminescence, such as from deep-sea organisms
New frontiers
at Avidity

Avidity is a company with vision. We are moving into greater investigation of bioluminescence, such as from deep-sea organisms. Also, much attention is focused on development of new, novel luciferases that may be useful in new methods for the detection and quantification of DNA and protein-protein interactions.